Chromatography
How To Progress Safe and Effective Cell Therapies for Clinical Use
Jan 04 2012
Sistemic believe cell characterisation is an essential element in progressing safe and effective cell therapies for mainstream clinical use. They offer unique miRNA analytical services that provide reliable and costeffective, characterisation and QC tools that are applicable to all cell systems. Toward this end, Dr Vincent O’Brien (Chief Scientific Officer) and Dr Verna McErlane (Director of Commercial Operations, International) presented data supporting the utility of miRNA in the provision of superior cell characterisation and QC methods at the Stem Cells Europe conference in July.
Dr Vincent O’Brien presented a poster entitled ‘A novel microRNA-based stem cell characterisation and monitoring tool’, and Verna McErlane joined: Marilyn Robertson, SSCN; Aidan Courtney, Roslin Cells; Dr David Hay, Fibromed; and Michael Leek, Immunosolv, at the Scottish Stem Cell Network (SSCN) Panel showcase, ‘Progress to Therapy and Market’. Sistemic Ltd are a global company offering unique miRNA-based products and services such as SistemQCTM, designed for the sophisticated molecular characterisation of cells, which combines robust miRNA profiling, statistical analysis and contextual analysis.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia